# FDA approved Yescarta CAR-T for relapsed or refractory large B-cell lymphoma

Date: 2017

_No public text on this fact yet._

## Drivers

- Biotechnology Innovation: https://factrail.ai/drivers/biotechnology-innovation

## Sources

_Sources are listed on the canonical page._

## Methodology

https://factrail.ai/methodology

Canonical: https://factrail.ai/facts/fda-yescarta-car-t-lymphoma-approval-2017